Literature DB >> 27888911

Revision Functional Endoscopic Sinus Surgery.

Corinna G Levine1, Roy R Casiano2.   

Abstract

Refractory chronic rhinosinusitis can be challenging to treat. Initial treatment focuses on medical and nonsurgical treatments. If these treatments fail, revision endoscopic sinus surgery is an option. A plan for revision surgery must address anatomic factors contributing to recurrence. Preoperative imaging and sinonasal endoscopy are systematically reviewed; areas of disease and "danger" zones are identified. Traditional anatomic landmarks are often obscured or absent; thus, a set of consistent landmarks (unchanged despite prior surgery) are used to navigate the revision endoscopic sinus surgery. Wide sinusotomies permit visualization and access to disease intraoperatively. Large sinus openings also facilitate post-operative debridements in clinic, endoscopic disease monitoring, and topical sinus therapy. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Keywords:  Chronic rhinosinusitis; Neo-osteogenesis; Polyps; Refractory rhinosinusitis; Revision FESS; Scarring; Stenosis

Mesh:

Year:  2017        PMID: 27888911     DOI: 10.1016/j.otc.2016.08.012

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  9 in total

1.  Computed tomography assessment of anterior ethmoidal canal dehiscence: An interobserver agreement study and review of the literature.

Authors:  Angela Guarnizo; Thanh B Nguyen; Rafael Glikstein; Nader Zakhari
Journal:  Neuroradiol J       Date:  2020-03-02

2.  Study on the effects of desloratadine citrate disodium on the postoperative complications and inflammatory response in patients with chronic sinusitis undergoing endoscopic sinus surgery.

Authors:  Ming Ma; Longsheng Liu; Wei Jin; Hong Chen; Tao Zhou; Busheng Tong
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

3.  Characteristics of Chronic Rhinosinusitis with Nasal Polyps Based on Allergic Mucin and Fungal Elements in Patients Undergoing Revision Endoscopic Sinus Surgery.

Authors:  Lisa Mary Cherian; Rakesh R Bright; Lalee Varghese; V Rupa; Regi Kurien
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2021-08-27

4.  Conservative non-surgical management in medication related osteonecrosis of the jaw: A retrospective study.

Authors:  Massimo Albanese; Francesca Zotti; Giorgia Capocasale; Stefano Bonetti; Fabio Lonardi; Pier Francesco Nocini
Journal:  Clin Exp Dent Res       Date:  2020-07-02

5.  The role of structured reporting and structured operation planning in functional endoscopic sinus surgery.

Authors:  Benjamin Philipp Ernst; Manuel René Reissig; Sebastian Strieth; Jonas Eckrich; Jan H Hagemann; Julia Döge; Christoph Matthias; Haralampos Gouveris; Johannes Rübenthaler; Roxanne Weiss; Wieland H Sommer; Dominik Nörenberg; Thomas Huber; Phillipp Gonser; Sven Becker; Matthias F Froelich
Journal:  PLoS One       Date:  2020-11-30       Impact factor: 3.240

6.  Host and Surgical Factors Affecting the Frequency and Duration of Revision Endoscopic Sinus Surgery.

Authors:  Erdinc Cekic
Journal:  Cureus       Date:  2022-09-15

7.  Effect of Topical Furosemide Efficacy on Reducing Bleeding and Quality of Surgical Field During Endoscopic Sinus Surgery in Patients with Chronic Rhinosinusitis.

Authors:  Javaneh Jahanshahi; Mohammad Ghorbani; Farnaz Hashemian; Farshad Hashemian; Mojgan Sheikhi; Elham Khanlarzadeh
Journal:  Iran J Otorhinolaryngol       Date:  2022-09

8.  The Pneumatization and Adjacent Structure of the Posterior Superior Maxillary Sinus and Its Effect on Nasal Cavity Morphology.

Authors:  Liu Jinfeng; Dai Jinsheng; Wen Xiaohui; Wang Yanjun; Wang Ningyu
Journal:  Med Sci Monit       Date:  2017-08-29

Review 9.  Are errors in otorhinolaryngology always a sign of medical malpractice? Review of the literature and new perspectives in the SARS-CoV-2 (COVID-19) era.

Authors:  Polychronis Voultsos; Antonio Oliva; Simone Grassi; Debora Palmiero; Antonio Gioacchino Spagnolo
Journal:  Acta Otorhinolaryngol Ital       Date:  2020-06-10       Impact factor: 2.124

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.